Highlights

Professor Glenn King is a biochemist and structural biologist whose expertise lies in translating venom-derived peptides into human drugs and bioinsecticides. His lab maintains the most extensive collection of venoms in the world, which includes venoms from more than 600 species of venomous spiders, scorpions, centipedes and assassin bugs.

Professor King’s primary focus is on the development of drugs to treat three pervasive nervous system disorders: chronic pain, epilepsy, and stroke. His lab is working closely with several pharmaceutical companies to develop drugs for clinical use.

Professor King has also charted new territory in the field of agriculture by developing venom peptides as eco-friendly bioinsecticides. Vestaron Corporation, the company that he founded, will begin selling these bioinsecticides in the U.S. market in 2017.

Mentorship is important to Professor King, and he is enthusiastically committed to training the next generation of biological scientists. To date he has trained 30 PhD students and 24 postdoctoral scientists, with 10 lab alumni having gone on to independent academic positions.

Connect